Marrone Bio Innovations, Inc., a biopesticide company, engages in the discovery, development, and marketing of natural products for weed, pest, and plant disease management. Its products include Regalia, a product that protects food and ornamental crops from fungal and bacterial diseases; GreenMatch EX, a postemergence herbicide for burndown weed control for organic growers; and GreenMatch, a burndown herbicide that controls various annual and perennial weeds. The Company also offers insecticides, herbicides, and products for controlling invasive zebra and quagga mussels in waterways. In addition, it finds naturally occurring microorganisms from habitats and develops them into products for controlling insects, weeds, nematodes, and plant diseases.

Type
Public
HQ
Davis, US
Founded
2006
Size (employees)
97 (est)
Marrone Bio Innovations was founded in 2006 and is headquartered in Davis, US
Report incorrect company information

Key People/Management at Marrone Bio Innovations

Pam Marrone

Pam Marrone

Founder and CEO
Keith Pitts

Keith Pitts

Vice President, Regulatory Affairs

Marrone Bio Innovations Office Locations

Marrone Bio Innovations has an office in Davis
Davis, US (HQ)
2121 Second St.
Davis, US
1540 Drew Ave
Show all (2)
Report incorrect company information

Marrone Bio Innovations Financials and Metrics

Marrone Bio Innovations Financials

Marrone Bio Innovations's revenue was reported to be $14.04 m in FY, 2016 which is a 43.3% increase from the previous period.
USD

Revenue (Q3, 2017)

4.2 m

Net income (Q3, 2017)

(8.5 m)

EBIT (Q3, 2017)

(6.6 m)

Market capitalization (18-Apr-2018)

54 m

Cash (30-Sep-2017)

3.7 m

EV

52 m
Marrone Bio Innovations's current market capitalization is $54 m.
Annual
USDFY, 2013Y, 2014FY, 2015FY, 2016

Revenue

14.5 m1.1 m9.8 m14 m

Revenue growth, %

(92%)793%43%

General and administrative expense

18.5 m

Operating expense total

18.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

1.3 m2.8 m3.6 m2.1 m3.4 m2.5 m2.7 m5 m3.6 m4.2 b6.5 b4.2 m

General and administrative expense

4.5 m6.3 m6 m7.9 m7.4 m5.3 m5.5 m4.5 m3.8 m5.3 b5.1 b5.2 m

R&D expense

4.5 m

Operating expense total

8.9 m10.6 m10.3 m11.3 m10.7 m8.8 m7.9 m6.8 m6.4 m7.8 b7.9 b8.3 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

24.5 m35.3 m19.8 m9.6 m

Accounts Receivable

6.2 m1.8 m2.3 m3.6 m

Inventories

1.7 m1.3 m1.3 m8.5 m

Current Assets

58.7 m54.7 m36 m26.9 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

40.8 m21.3 m57.6 m22.4 m12.2 m27.8 m9.8 m21.2 m16 m1.8 m10.2 m3.7 m

Accounts Receivable

2.1 m7.2 m4.1 m2.2 m3 m1.4 m4.7 m4.5 m2.1 m8.1 m5.8 m1.9 m

Inventories

10.8 m12.8 m12.5 m11.8 m10.6 m9.8 m8.6 m8 m8.4 m8.1 m8.4 m9.3 m

Current Assets

68.6 m47 m80.1 m41.1 m30.2 m43.4 m28.1 m37.8 m30.6 m24.4 m29.6 m19.5 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.5 m)(16.2 m)(43.7 b)(31.1 m)

Depreciation and Amortization

976 k2.2 m

Inventories

(6.8 m)1.3 m582 k

Accounts Payable

1.7 m5.8 m(588 k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(6.1 m)(10.2 m)(10.4 m)(11.9 m)(22.9 m)(32.7 m)(9.3 m)(16.1 m)(23.3 m)(7.6 b)

Depreciation and Amortization

833 k1.7 m2.6 m594 k1.2 m1.7 m

Inventories

869 k2 m2.9 m504 k1.1 m659 k

Accounts Payable

8.6 m5.2 m(1.6 m)(2.3 m)(4.4 m)583 k196 k223 k3 m
USDY, 2017

EV/EBIT

-7.9 x

Revenue/Employee

43.5 k

Financial Leverage

-0.9 x
Show all financial metrics
Report incorrect company information